Statement Of Investor Grievances For The Quarter Ended 31St December, 2017.
In terms of Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Statement of Investor Grievances for the quarter ended 31st December, 2017. Kindly take the same on record. Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Closure of Trading Window
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th December, 2017 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and nine months ended 31st December, 2017 are communicated to the Stock Exchanges. Notice of Postal Ballot
This is to inform you that the Company is in the process of conducting postal ballot (including voting by electronic means) for seeking approval of members of the Company for businesses as specified in the Postal Ballot Notice dated 10th November, 2017. In terms of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Postal Ballot Notice dated... Alkem Labs Q2 net up 14% at Rs 327 cr on robust sales
Consolidated total income of the company stood at Rs 1,888.95 crore Updates
We refer to our earlier communication dated 28th September, 2017 regarding closure of trading window (for the purpose of financial results for the quarter and half year ended 30th September, 2017) starting from 29th September, 2017 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half year ended on 30th September, 2017 are communicated to the Stock Exchanges.... Press Release / Media Release
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY18 and H1FY18 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same. Financial Results For Quarter And Half Year Ended 30Th September, 2017
In continuation of our letter dated 1st November, 2017 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2017, duly approved by the Board of Directors of the Company, at its meeting... Outcome of Board Meeting
In continuation of our letter dated 1st November, 2017 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2017, duly approved by the Board of Directors of the Company, at its meeting... Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY18 and H1FY18 financial results will be held on Friday, 10th November, 2017 at 5.00 P.M. Please find attached herewith the conference call details. Kindly take note of the same.